Background-Cardiac dysfunction in failing hearts of human patients and animal models is associated with both microtubule densification and transverse-tubule (T-tubule) remodeling. Our objective was to investigate whether microtubule densification contributes to T-tubule remodeling and excitation-contraction coupling dysfunction in heart disease. Methods and Results-In a mouse model of pressure overload-induced cardiomyopathy by transaortic banding, colchicine, a microtubule depolymerizer, significantly ameliorated T-tubule remodeling and cardiac dysfunction. In cultured cardiomyocytes, microtubule depolymerization with nocodazole or colchicine profoundly attenuated T-tubule impairment, whereas microtubule polymerization/stabilization with taxol accelerated T-tubule remodeling. In situ immunofluorescence of heart tissue sections demonstrated significant disorganization of junctophilin-2 (JP2), a protein that bridges the T-tubule and sarcoplasmic reticulum membranes, in transaortic banded hearts as well as in human failing hearts, whereas colchicine injection significantly preserved the distribution of JP2 in transaortic banded hearts. In isolated mouse cardiomyocytes, prolonged culture or treatment with taxol resulted in pronounced redistribution of JP2 from T-tubules to the peripheral plasma membrane, without changing total JP2 expression. Nocodazole treatment antagonized JP2 redistribution. Moreover, overexpression of a dominant-negative mutant of kinesin 1, a microtubule motor protein responsible for anterograde trafficking of proteins, protected against JP2 redistribution and T-tubule remodeling in culture. Finally, nocodazole treatment improved Ca 2+ handling in cultured myocytes by increasing the amplitude of Ca 2+ transients and reducing the frequency of Ca 2+ sparks. Conclusion-Our data identify a mechanistic link between microtubule densification and T-tubule remodeling and reveal microtubule-mediated JP2 redistribution as a novel mechanism for T-tubule disruption, loss of excitation-contraction coupling, and heart failure. (Circulation. 2014;129:1742-1750.)
M icrotubules, which are ubiquitous cytoskeletal fibers formed by polymerization of α-and β-tubulin dimers, regulate a wide range of cellular processes, including maintenance of cell shape, mitosis, and intracellular protein transport. In human hypertrophied and failing myocardium, tubulin expression levels were increased. 1, 2 In patients and animal models with symptomatic aortic stenosis, an increase in microtubule density, namely, microtubule densification, was found to be inversely related with left ventricular (LV) fractional shortening. 3, 4 Epidemiological studies demonstrate that the microtubule stabilizing agent taxol (also paclitaxel), an important antineoplastic chemotherapy agent, is associated with cardiotoxicity, including myocardial infarction, ventricular tachycardia, and congestive heart failure. [5] [6] [7] Conversely, colchicine, a microtubule depolymerizing agent used to treat gout, decreases the incidence of myocardial infarction. 8 Microtubule densification is a common observation in multiple animal models of cardiac disease. 4, 9, 10 Studies performed in canine, feline, guinea pig, rat, and murine models consistently demonstrated that microtubule depolymerization attenuates cardiac dysfunction. [11] [12] [13] [14] [15] For example, in a canine model of pressure overload-induced LV hypertrophy, treatment with colchicine normalizes both in vivo and in vitro cardiac contractile function. 11 Thus, multiple lines of evidence suggest a clear role for microtubule destabilization in the preservation of cardiac function, yet the mechanism by which microtubule densification results in loss of cardiac function remains incompletely understood. 16, 17 Clinical Perspective on p 1750
Defective excitation-contraction (E-C) coupling is a hallmark of heart failure. [18] [19] [20] Emerging evidence demonstrates that disruption of the transverse-tubule (T-tubule) network is mechanistically involved in the development and progression of heart failure. 21, 22 T-tubules are highly organized invaginations of surface membrane that form tightly physical couplings with the terminal cisternae of the sarcoplasmic reticulum (SR), termed cardiac dyads. 23 Precise communication between the voltage-gated L-type Ca 2+ channels located mainly on the T-tubule membrane and Ca 2+ release ryanodine receptor channels on the SR is essential for rapid electric excitation, initiation, and synchronous triggering of SR Ca 2+ release and therefore coordinated myocyte contraction. 24, 25 Junctophilin-2 (JP2), a member of the junctophilin family, spans the T-tubule and SR membranes and thereby plays an important role in the formation and maintenance of the cardiac dyad. 26 Loss of JP2 expression results in T-tubule remodeling after pressure overload, as demonstrated by studies in cultured myocytes and a transgenic mouse model expressing JP2 short-hairpin RNA. 22, 27 Despite the substantial association in cardiac dysfunction between T-tubule remodeling and microtubule densification, it remains unclear whether the latter 2 processes are mechanistically linked in the development of heart failure. In addition, progressive loss of T-tubule integrity is a long-standing and well-known phenotype in cultured adult cardiomyocytes. [28] [29] [30] Related unresolved questions are how progressive T-tubule loss occurs in cultured myocytes and whether it shares common mechanisms with T-tubule remodeling in vivo in response to cardiac stress.
Using a transaortic banding (TAB) murine pressure overload cardiomyopathy model, we first established that treatment with the microtubule disrupting agent colchicine preserves cardiac function and T-tubule integrity as demonstrated by in situ confocal imaging of Langendorff-perfused intact hearts. Our studies in cultured cardiomyocytes provided key mechanistic insights into how microtubules regulate T-tubule remodeling. Specifically, myocytes in culture undergo progressive loss of T-tubule organization with extended culture, accompanied by rearrangement and densification of microtubules. Microtubule polymerization/stabilization with taxol accelerates this T-tubule alteration, whereas microtubule depolymerization is protective. Genetic silencing of JP2 using an inducible cardiac-specific JP2 short-hairpin RNA abrogates the protective effect of microtubule disruption. Moreover, pressure overload or microtubule stabilization induces marked redistribution of JP2 to the cell periphery, similar to that observed in failing human hearts. Last, overexpression of a dominant-negative mutant of microtubule motor protein kinesin 1 (also known as Kif5b) protected against JP2 redistribution and T-tubule remodeling. Analysis of Ca 2+ handling properties demonstrate that microtubule depolymerization rescues E-C coupling, including an increase in the amplitude of Ca 2+ transients and a reduction of Ca 2+ sparks. These data collectively indicate that microtubule densification contributes to T-tubule remodeling in heart failure by altering JP2 distribution within the membrane system.
Methods

Human Heart Samples
LV samples from patients with ischemic or dilated cardiomyopathies were obtained from explanted hearts at the University of Iowa Heart Failure Transplant Program. Nonfailing donor hearts without evidence of overt cardiac dysfunction were obtained through organ donor networks/organ procurement agencies. For immunostaining experiments, a total of 10 LV samples were studied, including 3 rejected healthy donor hearts and 7 end-stage heart failure patients with either ischemic heart disease (4) or dilated cardiomyopathy (3). All human heart tissue samples were obtained under organ research donation protocols approved by the Institutional Review Boards at the University of Iowa and Mayo Clinic.
Animal Studies and Experimental Methods
Animal experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (publication no. 85-23, revised 1996) and were approved by the Institutional Animal Care and Use Committee at the University of Iowa. All mice used in the study were in the C57BL/6 background. All experiments were performed in male mice aged 2 to 3 months. The numbers of mice and myocytes for each experimental group are provided in the figures or figure legends.
For detailed experimental methods, see the online-only Data Supplement.
Statistics
Data are expressed as mean±SE. One-way ANOVA with Bonferroni post hoc test was applied to multiple-group comparisons of in vivo animal experiments. The Bonferroni procedure after a global test based on a linear mixed-effects model was performed for multiple-group comparisons of in vitro cardiomyocyte experiments. A compound symmetry correlation structure was assumed for linear mixed-effects model tests. Student t test was used for 2-group comparisons. Statistical analyses were performed using SPSS version 15.0 (SPSS). Values of P<0.05 were considered statistically significant.
Results
Microtubule Depolymerization Attenuates In Vivo T-Tubule Remodeling After Pressure Overload-Induced Hypertrophy
Several studies demonstrated that microtubule stabilization and accumulation is associated with the loss of cardiac function after cardiac stress, yet the mechanisms remain incompletely understood. We hypothesized that microtubule stabilization is involved in T-tubule remodeling after pressure overload. In vehicle-treated mice, TAB produced severe T-tubule disorganization and subcellular T-tubule loss as demonstrated by in situ confocal imaging of the LV ( Figure 1A ). Whereas colchicine injection had no effect on T-tubule organization in the LV of sham mice, it protected T-tubule structure against pressure overload-induced remodeling ( Figure 1A) . To quantify the integrity of T-tubules, we conducted a power spectrum analysis of the strength of T-tubule structural integrity. The T-tubule power spectrum analysis demonstrated a marked decrease in the T-tubule integrity in the LV of TAB mice compared with sham mice ( Figure 1B) . Colchicine treatment attenuated the decrease microtubule density ( Figure 2A ) and both free and polymerized β-tubulin ( Figure 2B ) were increased in pressure-overloaded LV compared with the sham group. Colchicine injection markedly attenuated the pressure overload-induced microtubule densification (Figure 2A and 2B; see Figure I in the online-only Data Supplement). In addition, treatment with colchicine improved survival ( Figure 2C ), ameliorated TAB-induced cardiac dysfunction ( Figure 2D through 2F), and had little effect on the heart weight/body weight ratio ( Figure 2G ). These data suggest that microtubule stabilization is involved in T-tubule remodeling and associated cardiac dysfunction induced by pressure overload.
Microtubule Depolymerization Protects T-Tubule Structure in Cultured Cardiomyocytes
Studies were next extended to cultured cardiomyocytes to investigate the mechanisms underlying the T-tubule protection by microtubule depolymerization. We first established reorganization and assembly of the microtubule network adjacent to the sarcolemma after 48 to 72 hours in culture ( Figure 3A ). Microtubule densification, as seen in culture for a longer time (48 and 72 hours), was abrogated by another microtubule depolymerizing agent, nocodazole ( Figure 3A) . The increase in microtubule stability during culture was accompanied by progressive T-tubule loss and disorganization ( Figure 3B and 3C ). Similar to our in vivo data, treatment of cultured cardiomyocytes with colchicine or nocodazole pronouncedly attenuated the progressive loss of T-tubule organization ( Figure 3B and 3C).
To confirm the role of microtubule stabilization in T-tubule remodeling, cardiomyocytes were treated with taxol, a microtubule polymerizing agent. Taxol treatment exaggerated the densification and aggregation of the microtubule network, especially at 72 hours ( Figure 4A ). Disorganization of T-tubules was also exacerbated in cardiomyocytes treated with taxol for 72 hours compared with control cardiomyocytes, and this effect was antagonized by nocodazole treatment ( Figure 4B and 4C). These data provide additional evidence that microtubule stabilization is associated with 
JP2 Silencing Abolishes the T-Tubule Protection by Nocodazole
We reported recently that JP2, which tethers T-tubules to the SR and is a critical safeguard of the cardiac dyad, is required to maintain T-tubule integrity. 22 To examine whether JP2 is involved in the microtubule densification-mediated T-tubule disorganization, we next performed studies in mice that express a cardiac-specific tamoxifen-inducible JP2 short-hairpin RNA. 27 Figure 5A demonstrates robust JP2 silencing in hearts from JP2 knockdown (JP2-KD) mice after 10-day tamoxifen injection
; for an incomplete KD with lower dosage or shorter injection period, see Figure II in the online-only Data Supplement). Cardiomyocytes freshly isolated from JP2-KD mice demonstrated significant disorganization of T-tubules ( Figure 5B ). In contrast to wild-type hearts, treatment with nocodazole failed to protect JP2-KD myocytes from T-tubule remodeling associated with culture ( Figure 5C and 5D). These data indicate that JP2 is required for mediating the protective effect of microtubule depolymerization on T-tubule architecture.
Microtubule Stabilization Induces JP2 Redistribution from T-Tubules to Peripheral Plasma Membrane
We next investigated how microtubule depolymerization affects JP2 expression and subcellular distribution. Nocodazole had no effect on JP2 mRNA or protein levels in cultured cardiomyocytes (see Figure IIIA and IIIB in the online-only Data Supplement). Additional Western blotting assay with cytosolic and membrane fractions indicates that JP2 was primarily located on the 
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April 29, 2014 membrane in cardiomyocytes. Nocodazole treatment for 48 hours did not alter its membranous distribution (see Figure IIIC in the online-only Data Supplement). In intact hearts, in situ immunofluorescence staining showed that JP2 was organized in regular striations similar to T-tubules ( Figure 6A, left) . This staining pattern did not distinguish cell boundaries, which suggests that JP2 is primarily localized to the T-tubule regions in normal hearts. However, after TAB in mouse hearts, we detected a significant redistribution of JP2 protein, with punctate staining and aggregations ( Figure 6A , middle). Colchicine injection pronouncedly attenuated the TAB-induced redistribution of JP2 ( Figure 6A , right). More importantly, the same phenotype was observed in tissue sections of failing human hearts of both ischemic and dilated cardiomyopathies ( Figure 6B ). These data suggest that JP2 undergoes a profound reorganization after cardiac stress.
To better understand the nature of JP2 disorganization after cardiac stress, we next performed studies in cultured cardiomyocytes. Compared with freshly isolated myocytes (0 hours), the organized JP2 distribution was altered after 48 hours, with a more pronounced effect after prolonged culture for 72 hours ( Figure 6C ). As a quantitative index of the regularity of JP2 staining, we calculated the peak JP2 power value at the dominant frequency, using the same power spectrum analysis as for TTpower. Peak JP2 power was reduced after 48 hours in culture and more dramatically at 72 hours ( Figure 6D ). In addition, at 48 hours in culture, we observed a clear accumulation of JP2 around the edge of myocytes, suggesting a reorganization of JP2 protein during culture. More dramatically, at 72 hours, a significant amount of JP2 was redistributed from the T-tubule membrane to the periphery plasma membrane ( Figure 6C and 6E ). Microtubule depolymerization with nocodazole prevented the culture-associated disorganization of JP2 within the T-tubule network, as well as the redistribution to the peripheral membrane ( Figure 6C through 6E) . Treatment with taxol accelerated the culture-induced redistribution of JP2, and this effect was antagonized by nocodazole ( Figure 6C through 6E). These data collectively demonstrate that microtubule stabilization results in JP2 redistribution without changes in JP2 expression, suggesting that the T-tubule remodeling associated with microtubule stabilization is mediated by alteration of normal JP2 localization.
Kinesin 1 Is Involved in Microtubule Polymerization-Mediated Abnormal Trafficking of JP2 Protein
Microtubule motor proteins kinesin 1 and dynein are responsible for the forward and retrograde trafficking of cargos along microtubules, respectively. To test whether inhibition of retrograde trafficking affects T-tubule remodeling in cultured cardiomyocytes, we used the dynein inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine and ciliobrevin D. Neither 300 μmol/L erythro-9-(2-hydroxy-3-nonyl) adenine nor 50 μmol/L ciliobrevin D treatment for 48 hours altered T-tubule structure and JP2 redistribution in cultured cardiomyocytes compared with that of control ( Figure 7A and 7B ). In contrast, overexpression of a dominant-negative mutant of kinesin (Kif5b) protected against cultured-induced T-tubule remodeling, as well as JP2 redistribution to the cell periphery ( Figure 7C and 7D) compared with that of expressing wild-type Kif5b. These data suggest a role for the anterograde trafficking of kinesin 1, but not the retrograde trafficking of dynein, of JP2 in microtubule densification-mediated T-tubule reorganization.
Protected T-Tubule Structure by Microtubule Depolymerization Preserves Ca 2+ Handling
A fundamental effect of T-tubule remodeling in cardiomyocytes is defective E-C coupling between T-tubule and SR. Accordingly, cultured cardiomyocytes paced at 1 Hz displayed depressed amplitude and prolonged time to peak of Ca 2+ transients compared with freshly isolated myocytes ( Figure 8A and 8B). Nocodazole treatment normalized these alterations. Under resting conditions, the activity of spontaneous Ca 2+ sparks reflects the gating of ryanodine receptors on the SR. We detected a dramatic increase in spontaneous Ca 2+ sparks in control cells after culture for 48 hours compared with freshly isolated cardiomyocytes ( Figure 8C and 8D) . Nocodazole treatment markedly reduced the frequency of Ca 2+ sparks without affecting other parameters ( Figure 8C and 8D) . These data suggest that microtubule depolymerization plays an important role in preserving myocyte Ca 2+ handling function by maintaining the normal architecture of E-C coupling machinery.
Discussion
The relationship between microtubule densification and loss of myocyte contractility in decompensated hypertrophied hearts was established >20 years ago.
1,31-33 Our study using a murine model of chronic pressure overload-induced cardiomyopathy provides new insights by mechanistically linking microtubule accumulation and T-tubule remodeling, which leads to impaired E-C coupling and heart failure. The major findings of our study are as follows: (1) depolymerizing microtubules in vivo mitigated TAB-induced T-tubule remodeling and heart failure; (2) densification of microtubules was accompanied by T-tubule impairment, and attenuation of microtubule densification using microtubule depolymerizers mitigated T-tubule alterations; (3) the normal distribution of JP2 was altered in pressure-overloaded mouse hearts, as well as in human diseased hearts; (4) microtubule densification resulted in JP2 redistribution from T-tubules to the cell periphery, which was preventable by microtubule depolymerization; (5) the protective effect of microtubule depolymerization on T-tubules was abolished in cardiomyocytes from JP2-KD mice; (6) overexpressing a dominant-negative mutant of Kif5b prevented the culture-induced JP2 redistribution and T-tubule damage; and (7) microtubule depolymerization preserved cytosolic Ca 2+ transients and markedly reduced spontaneous Ca 2+ sparks in cultured cardiomyocytes. Together, these data implicate the critical role of microtubule densification in the mechanism of T-tubule remodeling and loss of E-C coupling in pressure overload-induced cardiomyopathy.
Cardiac E-C coupling relies on precise positioning of ion channels, transporters, and related regulatory/structural proteins. Microtubules form an intricate and dynamic network capable of shuttling protein-containing vesicles to proper destinations. [34] [35] [36] [37] It appears clear that the microtubule is in close approximation with E-C coupling machinery, such as T-tubular-SR junctions, 38 whereby microtubules may modulate adjacent ryanodine receptor 2 activities. 39, 40 It is also suggested that microtubules are critical in maintaining the structural integrity of the SR network in ventricular myocytes. 41 Microtubule accumulation and densification attributable to increased expression of tubulin and formation of stable microtubules have been observed in multiple models of cardiac hypertrophy, at both the compensated and decompensated stages. 1, 10, 14 It was established soundly that the densification of microtubule network contributes to the cardiac dysfunction in decompensated hypertrophy by 2 reported mechanisms. First, accumulation of microtubules increases the stiffness of the cell and mechanically impedes sarcomere motion. 14, 31 Second, microtubule densification alters E-C coupling, including Ca 2+ influx and SR Ca 2+ release, but this remains controversial. 16, 17 Elevation of stable microtubules occurred during both compensated and decompensated stages. 1, 10, 14 It began at the onset of cardiac hypertrophy and was involved in early hypertrophic response of myocardium induced by pressure overload. 10 These studies led us to hypothesize that microtubule densification might also be involved in chronic cardiac remodeling, such as T-tubule remodeling. 22, 42 Like microtubule densification, loss of T-tubule structural integrity is evident in compensated hypertrophy and progressively deteriorates with the development of heart failure. 22, 43 Loss of T-tubule integrity alters the spatial distribution of L-type Ca 2+ channels and increases "orphaned" ryanodine receptors, 44 which leads to reduced amplitude and slower rise of Ca 2+ release. 29, 44 We found that, in both intact pressure-overloaded hearts and cultured cardiomyocytes, treatment with microtubule depolymerizing agents attenuated T-tubule impairment. Moreover, microtubule depolymerization preserved the amplitude of Ca 2+ transients and reduced the frequency of Ca 2+ sparks. Thus, our data provide a clear mechanistic link between microtubule densification, T-tubule remodeling, and E-C coupling dysregulation. Our study also resolves a long-lasting question in the field: what mediates the progressive loss of T-tubules associated with prolonged culture of isolated primary cardiomyocytes? [28] [29] [30] 45 In the present study, our data not only suggest a link between microtubule densification and T-tubule remodeling but also provides mechanistic insights by implicating JP2 redistribution in this process in cultured myocytes. Moreover, our data also suggest that this is a common mechanism in cultured cardiomyocytes and in vivo after cardiac stress.
We and others reported a critical role for JP2 in T-tubule integrity such that deficiency of JP2 impairs T-tubule maturation during cardiac development 46 and accelerates T-tubule remodeling and loss of E-C coupling under pathological conditions. 22, 27 JP2 expression is markedly reduced in diseased hearts. 22, 42, 47, 48 One mechanism is through microRNA-mediated gene silencing. 49 JP2 is also regulated at the posttranslational level via degradation by the Ca 2+ -dependent proteolysis. 50 Our data herein complement these studies by providing new evidence that JP2 is required for the protective effect of microtubule depolymerization on T-tubule structure after cardiac stress. As an additional mechanism, we identified altered JP2 localization from the T-tubule membrane to the surface plasma membrane in response to stresses that induce microtubule densification. The mechanism likely involves enhanced anterograde trafficking of JP2 to the cell periphery. Our data indicate that the densification and likely reorganized microtubule network influence the redistribution of JP2 within the membrane system, thereby inducing T-tubule remodeling and E-C coupling dysfunction and contributing to the development of heart failure.
We reported recently that β-adrenergic blockage improves T-tubule remodeling and cardiac function after myocardial infarction through restoration of JP2 protein expression. 42 In the present study, our data suggest that microtubule densification-mediated JP2 redistribution represents another mechanism associated with heart failure. Thus, in addition to maintaining expression of JP2, proper localization of JP2 to the T-tubule system is also critical for normal myocyte function.
In summary, we identify densification of microtubules as a cause of T-tubule remodeling in heart disease and in cultured adult cardiomyocytes. Our data implicate redistribution of JP2, a critical safeguard of the cardiac dyad, as a mechanism by which microtubule densification leads to T-tubule disruption, loss of E-C coupling, and heart failure. Our study also identifies a novel mechanism for JP2 dysregulation, that is, microtubule densification-mediated JP2 mistrafficking, complementary to other mechanisms of JP2 downregulation, such as microRNA-mediated gene silencing 49 and posttranslational degradation. 50 Together, these findings provide novel insights into the roles of microtubules and JP2 in the pathogenesis of heart failure, which may have important implications for future development of new therapeutic strategies to ameliorate cardiac remodeling and the progression of heart failure.
SUPPLEMENTAL MATERIAL Supplemental Methods
Thoracic aortic banding (TAB) model and colchicine treatment
Male C57BL/6 mice (9-10 weeks) were subjected to sham or pressure overload by TAB surgery as described. 1 _Colchicine (Sigma, St. Louis, MO, USA) was injected intraperitoneally from 2 days after the Sham or TAB procedure once every other day. The injections began with 0.4 mg/kg and progressed to 1 mg/kg (0.4 mg/kg, 0.6 mg/kg, 0.8 mg/kg and 1 mg/kg) to allow the mice to adjust to the drug, as previously described. 2 
